KingMed Diagnostics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Public

  • Employees
  • 9,529

Employees

  • Stock Symbol
  • 603882

Stock Symbol

  • Investments
  • 11

  • Share Price
  • $4.09
  • (As of Wednesday Closing)

KingMed Diagnostics General Information

Description

Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2024, KingMed has 50 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • No. 10, Spiral Third Road
  • 3rd Floor, International Bio Island
  • Guangzhou, Guangdong 510000
  • China
+86 020
Primary Industry
Laboratory Services (Healthcare)
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • No. 10, Spiral Third Road
  • 3rd Floor, International Bio Island
  • Guangzhou, Guangdong 510000
  • China
+86 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KingMed Diagnostics Stock Performance

As of 18-Nov-2026, KingMed Diagnostics’s stock price is $4.09. Its current market cap is $1.9B with 463M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.09 $4.12 $3.16 - $5.83 $1.9B 463M 12M $0.09

KingMed Diagnostics Financials Summary

As of 30-Sep-2026, KingMed Diagnostics has a trailing 12-month revenue of $855M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,822,171 1,658,998 1,603,247 3,944,564
Revenue 855,244 838,574 1,001,963 1,207,035
EBITDA 56,228 31,568 15,377 184,638
Net Income 40,611 (24,091) (53,131) 90,939
Total Assets 1,390,466 1,372,723 1,423,528 1,660,084
Total Debt 127,303 119,434 102,518 81,710
Public Fundamental Data provided by Morningstar, Inc. disclaimer

KingMed Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore KingMed Diagnostics‘s full profile, request access.

Request a free trial

KingMed Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore KingMed Diagnostics‘s full profile, request access.

Request a free trial

KingMed Diagnostics Patents

KingMed Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250257401-A1 Biomarker for tuberous sclerosis complex with no mutation identified in tsc1 or tsc2 gene, and uses thereof Pending 03-Nov-2022
WO-2024092942-A1 Biomarker for tuberous sclerosis complex-no mutation identified and use thereof Inactive 03-Nov-2022
WO-2022266790-A1 Method for reducing artificially introduced artefact mutations in high-flux sequencing, and application Inactive 21-Jun-2021
US-20240221866-A1 Method of reducing artefact variants in high throughput-sequencing and uses thereof Pending 21-Jun-2021
US-12579828-B2 Method and system for identifying target region of digital pathology slide, device, and medium Active 30-Nov-2020 G06V20/695
To view KingMed Diagnostics’s complete patent history, request access »

KingMed Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KingMed Diagnostics Investments (11)

KingMed Diagnostics’s most recent deal was a IPO with Distinct HealthCare for . The deal was made on 06-Feb-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Distinct HealthCare 06-Feb-2026 IPO Clinics/Outpatient Services
GeneMind 27-May-2025 PE Growth/Expansion Diagnostic Equipment
GeneMind 01-Aug-2023 Later Stage VC Diagnostic Equipment
Biotree (Laboratory Services) 20-Dec-2022 Later Stage VC Laboratory Services (Healthcare)
Guhai Tianmu 24-Jul-2021 Corporate Other Healthcare Technology Systems
You’re viewing 5 of 11 investments. Get the full list »

KingMed Diagnostics ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

26.33 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Services

Subindustry

of 97

Rank

Percentile

To view KingMed Diagnostics’s complete esg history, request access »

KingMed Diagnostics Exits (1)

KingMed Diagnostics’s most recent exit was on 07-Nov-2017 from AnchorDx. The exit was categorized as with 6 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
AnchorDx 07-Nov-2017 Completed
  • 6 buyers
To view KingMed Diagnostics’s complete exits history, request access »

KingMed Diagnostics FAQs

  • When was KingMed Diagnostics founded?

    KingMed Diagnostics was founded in 2006.

  • Where is KingMed Diagnostics headquartered?

    KingMed Diagnostics is headquartered in Guangzhou, China.

  • What is the size of KingMed Diagnostics?

    KingMed Diagnostics has 9,529 total employees.

  • What industry is KingMed Diagnostics in?

    KingMed Diagnostics’s primary industry is Laboratory Services (Healthcare).

  • Is KingMed Diagnostics a private or public company?

    KingMed Diagnostics is a Public company.

  • What is KingMed Diagnostics’s stock symbol?

    The ticker symbol for KingMed Diagnostics is 603882.

  • What is the current stock price of KingMed Diagnostics?

    As of 18-Nov-2026 the stock price of KingMed Diagnostics is $4.09.

  • What is the current market cap of KingMed Diagnostics?

    The current market capitalization of KingMed Diagnostics is $1.9B.

  • What is KingMed Diagnostics’s current revenue?

    The trailing twelve month revenue for KingMed Diagnostics is $855M.

  • What is KingMed Diagnostics’s annual earnings per share (EPS)?

    KingMed Diagnostics’s EPS for 12 months was $0.09.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process